Oral Phosphate Binders: Phosphate Binding Capacity of Iron (III) Hydroxide Complexes Containing Saccharides; and Their Effect on the Urinary Excretion of Calcium and Phosphate in Rats

References

• Alfrey A C, Zhu J M. The role of hyperphosphatemia. Am J Kidney Dis 1991; 17: 53–56
   PubMedGoogle Scholar
• Rubini M E, Coburn J W, Massry S G, Shinaber J H. Renal osteodystrophy: some therapeutic considerations relative to long term dialysis and transplantation. Arch Intern Med 1969; 124: 663–669
   PubMedGoogle Scholar
• Bricker N S. On the pathogenesis of the uremic state: an exposition of the “Trade-off Hypothesis”. N Engl J Med 1972; 286: 1093–1099
   PubMed Web of Science ®Google Scholar
• Slatopolsky E, Caglar S, Gradowska L, Canterbury J M, Reiss E, Bricker N S. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease usiing “proportionate reduction” of dietary phosphorus intake. Kidney Int 1972; 2: 147–151
   PubMed Web of Science ®Google Scholar
• Goodman W G. Bone disease and aluminum: Pathologic consideiations. Am J. Kidney Dis 1985; 6: 330–335
   PubMed Web of Science ®Google Scholar
• Coburn J W, Salusky I B. Control of serum phosphorus in uremia. N Engl J Med 1989; 320: 1140–1142
   PubMedGoogle Scholar
• Slatopolsky E, Caglar S, Pennell J P, Tagart D D, Canterbury J M, Reiss E, et al. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 1971; 50: 492–499
   PubMed Web of Science ®Google Scholar
• Lopez-Hilker S, Dusso A S, Rapp N S, Martin K J, Slatopolsky E. Phosphorous restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990; 259: F432–F437
   PubMed Web of Science ®Google Scholar
• Lucas P A, Brown R C, Woodhead J S, Coles G A. 1,25-Dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: Effects of simultarieous protein and phosphorus restriction. Clin Nephrol 1986; 25: 7–10
   PubMedGoogle Scholar
• Spencer H, Kramer L, Norris C, Osis D. Effect of small doses of aluminum containing antacids on calcium and phosphorus metabolism. Am J Clin Nutr 1982; 36: 32–40
   PubMed Web of Science ®Google Scholar
• Nebeker H G, Coburn J W. Aluminum and renal osteodystrophy. Ann Rev Med 1976; 37: 79–95
   Google Scholar
• Alfrey A C, LeGendre G R, Kaelney W D. The dialysis encephalopathy syndrome: possible aluminum intoxication. N Engl J Med 1976; 294: 184–188
   PubMed Web of Science ®Google Scholar
• Hodsman A B, Sherrard D J, Alfrey A C, Ott S, Bncknian A S, Miller N L, et al. Bone aliuminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 1982; 54: 539–546
   PubMed Web of Science ®Google Scholar
• O'Hare J A, Murnaghan D J. Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate. N Engl J Med 1982; 306: 654–656
   PubMed Web of Science ®Google Scholar
• Swartz R, Dombrouski J, Burnatowska-Hledin M, Mayor G. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity. Am J Kidney Dis 1987; 9: 217–223
   PubMed Web of Science ®Google Scholar
• Sheikh M S, Maguire J A, Emmett M, Santa Ana C A, Nicar M J, Schiller L R, et al. Reduction of dietary phosphorus absorption by phosphorus binders. J Clin Invest 1989; 83: 66–73
   PubMed Web of Science ®Google Scholar
• Fournier A, Monriniere P, Sebert J L, Dkhissi H, Atik A, Leflon P, et al. Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia. Kidney Int 1986; 18(Suppl 29)114(S)–119(S)
   Google Scholar
• Beall D P, Scofield R H. Milk-alkali syndrome associated with calcium carbonate consumption. Medicine 1995; 74: 89
   PubMed Web of Science ®Google Scholar
• Gonella M, Calabrese G, Vagelli G, Pratesi G, Lamori S, Talarico S. Effect of high CaCO3 supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment. Clin Nephrol 1985; 24: 147–150
   PubMed Web of Science ®Google Scholar
• Shi-Bing Jing, Yamaguchi T. Removal of phosphate from dilute phosphate solution bsy an iron chitosan comlex to be used as an oral sorbent. Bull Chem Soc Jpn 1992; 65: 1866–1870
   Google Scholar
• Yoshimoto H, Shi-Bing Jing, Yamaguchi T. Removal of phosphate by acetylated iron-chitosn. J Chem Soc Jpn 1995; 12: 1026–1027
   Google Scholar
• Yoshimoto H, Jing Shi-Bing, Yamaguchi T. Oral sorbents for acidic substances in urernic toxins. J Chem Soc Jpn 1995; 6: 486–489
   Google Scholar
• Yoshimoto H, Shi-Bing Jing, Yamaguchi T. Application of chitosan for oral sorbents. Chitin and Chitosan Research 1995; 1: 6–14
   Google Scholar
• Kuroda S, Komori M, Nagamatsu K, Ninomiya R, Maejima K, Hasegawa K, et al. Effect of iron as a new type of phosphate binder in hemodialysis patients. Jpn J Nephrol 1995; 37: 468–473
   Google Scholar
• Spengler K, Follmann H, Boos K, Seidel D, Von der Haar F, Elsner, et al. Cross-linked iron dextran is an efficient oral phosphate binder in the rat. Nephrol Dial Transplant 1996; 11: 808–812
   PubMed Web of Science ®Google Scholar
• Furugouri K. Effect of elevated dietary levels of iron on iron stores in liver, some blood constituents and phosphorus deficiency in young swine. J Anim Sci 1972; 34: 573–577
   PubMed Web of Science ®Google Scholar
• Okada M, Imamura K, Iida M, Fuchigami T, Omae T. Hypophosphataemia induced by intravenous administration of saccharated iron oxide. Klin Wochenschr 1983; 61: 99–102
   PubMedGoogle Scholar
• Goldberg D I, Dillon M A, Slatopolsky E A, Garrett B, Gray J R, Marbury T, et al. Effect of RenaGel®, a non-absorbed, calcium- and aluminum-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients. Nephrol Dial Transplant 1998; 13: 2303–2310
   PubMed Web of Science ®Google Scholar
• Burke S K, Slatopolsky E A, Goldberg D I. RenaGel®, a novel calcium- and aluminum-free phosphate binder, inhibits phosphate absorption in normal volunteers. Nephrol Dial Transplant 1997; 12: 1640–1644
   PubMed Web of Science ®Google Scholar
• Jing S B, Leishi L I, Daxi J L, Takiguchi Y, Yamaguchi T. Effect of chitosan on renal function in patients with chronic renal failure. J Pharm Pharmacol 1997; 49: 721–723
   PubMedGoogle Scholar
• Nishida M, Ookubo A, Hashimura Y, Ikawa A, Yoshimura Y, Ooi K, et al. Interaction of bovine serum albumin with the surface of a microcrystalline aluminum oxide hydroxide compound: a possible new type of phosphate adsorbent. J Pharm Sci 1992; 81: 828–831
   PubMedGoogle Scholar
• Nishida M, Yoshimura Y, Kawada J, Ookubo A, Kagawa T, Ikawa A, et al. Phosphate and pepsin adsorptions by a new boehmite compound and aluminum hydroxide. Biochem Int 1990; 22: 913–920
   PubMedGoogle Scholar
• Spengler K, Follmann H, Boss K S, Seidel D, Maywald F. Characterization and extracorporeal application of a new phosphate-binding agent. Eur J Clin Chem Clin Biochem 1994; 32: 733–739
   PubMedGoogle Scholar
• Rosenbaum D P, Holmes-Farley S R, Manderville W H, Pitruzzello M, Goldberg D I. Effect of RenaGel®, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats. Nephrol Dial Transplant 1997; 12: 961–964
   PubMed Web of Science ®Google Scholar
• Chertow G M, Burke S K, Lazarus J M, et al. Poly(allyamine hydrochloride) (RenalGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kid Dis 1997; 29: 66–71
   PubMed Web of Science ®Google Scholar
• Graff L, Bumel D. Reduction of dietary phosphorus absorption by oral phosphorus binders. Research Communications in Molecular Pathology and Pharmacology 1995; 90: 389–401
   PubMedGoogle Scholar
• Yoda S, Hoshino H, Yotsuyanagi T. Amorphous Iron (III) hydroxide as phosphate-binding agent for oral administration. J Chem Soc Jpn 1995; 1: 19–24
   Google Scholar
• Rao C P, Geetha K, Raghavan M S. Fe (III) complexes of D-glucose and D-fructose. BioMetals 1994; 7: 25–29
   Google Scholar
• Geetha K, Raghavan M S, Kulshreshtha S K, Sasikala R, Rao C P. Transition-metal saccharide chemistry: synthesis, spectroscopy, electrochemistry and magnetic susceptibility studies of iron (III) complexes of mono- and disaccharides. Carbohydr Res 1995; 271: 163–175
   Web of Science ®Google Scholar
• Nagy L, Gajda J, Kurti J, Schrantz K, Burger K. Spectroscopic studies of Iron (III) complexes of Dsaccharose and D-glucose in the solid state and in solution. J Radioanal Nucl Chem 1996; 209: 225–234
   Google Scholar
• Stefansson M. Selective complex formation of saccharides with europium (III) and iron (III) ions at alkaline pH studied by ligand-exchange chromatography. J Chromatog 1993; 630: 123–128
   Google Scholar
• Tonkovic M, Hadzija O, Nagy-Czako I. Preparation and properties of Fe (III)-sugar complexes. Inor Chim Acta 1983; 80: 251–254
   Web of Science ®Google Scholar
• Davis P S, Deller D J. Prediction and demonstration of iron chelating ability of sugars. Nature 1966; 212: 404–405
   PubMed Web of Science ®Google Scholar
• Stumm W, Furrer G, Wieland E, Zinder B. The effect of complex-forming ligands on the dissolution of oxides and aluminosilicates. The Chemistry of Weathering, J E Drever. D. Reidel Publishers, Hingham 1994; 55–74
   Google Scholar
• Schwertmann U, Kodama H, Fischer W R. Mutual interactions between organics and iron oxides. Interactions of Soil Minerals with Natural Organics and Microbes, P M Huang, M Schnitzer. SSSA Special Publication Number 17, Soil Science of America, Inc., Madison 1986; 239–244
   Google Scholar
• Gruenhagen S E, Schulze D G, Chansiri G, Hem K J, White J L, Hem S L. Effect of sorbitol on the phosphate adsorptive capacity of ferrihydrite suspensions. Pharm Dev Technol 1986; 2(1)81–86
   Google Scholar
• Nanzyo M. Infrared spectra of phosphate sorbed on iron hydroxide gel and the sorption products. Soil Sci Plant Nutr 1986; 32: 51–58
   Web of Science ®Google Scholar
• Brautbar N, Levine B S, Walling M W, Cobum J W. Intestinal absorption of calcium: role of dietary phosphate and vitamin D. Am J Physiol 1993; 241: 649–653
   Google Scholar
• Liang C T, Barnes J, Sacktor B, Balakir R A. Characterization of dietary phosphorus-dependent duodenal calcium uptake in vitamin D-deficient chicks. J Membranes Biol 1993; 134: 189–196
   PubMedGoogle Scholar
• Spencer H, Kramer L, Norris C, Osis D. Effect of small doses of aluminum-containing antacids on calcium and phosphorus metabolism. Am J Clin Nutr 1982; 36: 32–40
   PubMed Web of Science ®Google Scholar
• Kirsner J B. Effect of calcium carbonate, aluminum phosphate, and aluminum hydroxide on mineral excretion in man. J CIin Invest 1943; 22: 47–52
   PubMedGoogle Scholar
• Cuisinier-Gleizes P, George A, Giullano C, Mathieu H. Stimulation of bone resorption by phosphorus deprivation in the rat. Israel J Med Sci 1971; 7: 355
   PubMedGoogle Scholar